Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Medroxyprogesterone depot - Pfizer

Next Previous
Drug Profile

Medroxyprogesterone depot - Pfizer

Alternative Names: depo medroxyprogesterone acetate; Depo subQ in Uniject; Depo-subQ provera 104; DMPA -Pfizer; DMPA-SC; Medroxiprogesterone acetate; Sayana; Sayana Press; Sayana press

Latest Information Update: 08 Sep 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Pfizer
  • Class Anti-inflammatories; Antineoplastics; Hormonal replacements; Progesterone congeners; Progestogen-only oral contraceptives
  • Mechanism of Action Interleukin 6 receptor antagonists; Progesterone receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Pain; Pregnancy
  • Registered Endometriosis

Most Recent Events

  • 24 Jul 2025 Pfizer completes a phase I trial for Pregnancy (Prevention) in Belgium (SC) (EudraCT2021-001035-54) (NCT04893798)
  • 16 Sep 2021 Pfizer initiated enrolment in a phase I trial for Pregnancy (Prevention) in Belgium (SC) (EudraCT2021-001035-54) (NCT04893798)
  • 24 May 2021 Pfizer plans a phase I trial in Healthy volunteers (SC), In July 2021 (NCT04893798)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top